Form S-4/A - Registration of securities, business combinations: [Amend]

Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

Form S-4/A - Registration of securities, business combinations: [Amend]

0001213900-24-053881.txt

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more ARCA Biopharma Charts.

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more ARCA Biopharma Charts.

News ARCA Biopharma Inc

Form S-4/A - Registration of securities, business combinations: [Amend]
Dienstag 18 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 6 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm
Mittwoch 22 Mai 2024 (1 Monat vor) • PR Newswire (US)

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
Donnerstag 25 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Freitag 5 April 2024 (3 Monate vor) • PR Newswire (US)

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Mittwoch 3 April 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 7 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 1 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

ARCA biopharma Announces 2023 Financial Results
Donnerstag 1 Februar 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 1 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere ARCA Biopharma Inc News-Artikel

Rep Fse Oat Strip04 2048

Rep Serbia 33 A

NLBNPIT1WXJ8 20991231 12...

JPM EUR Corp Bond 1-5 yr...

Annaly Capital Management

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen